Molecular mechanisms underlying nutrient-stimulated incretin secretion.
about
Impact of postprandial glycaemia on health and prevention of diseasePhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseShort-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanismsDietary fiber in irritable bowel syndrome (Review)Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes.GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects.The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasisSustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetesA single amino acid in human APOBEC3F alters susceptibility to HIV-1 VifIncreased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.Identifying Ca2+-binding sites in proteins by liquid chromatography-mass spectrometry using Ca2+-directed dissociations.The delay in the development of experimental colitis from isomaltosyloligosaccharides in rats is dependent on the degree of polymerizationPancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapiesIncreased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidanceRecent developments in the pathophysiology of irritable bowel syndrome.The role of incretin therapy at different stages of diabetes.Mathematical Modeling of Interacting Glucose-Sensing Mechanisms and Electrical Activity Underlying Glucagon-Like Peptide 1 SecretionRole of gut nutrient sensing in stimulating appetite and conditioning food preferences.Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokininTherapy in the early stage: incretins.Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidanceRemoval of duodenum elicits GLP-1 secretion.Interaction between diet and gastrointestinal endocrine cells.Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetesDietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndromeRole of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic SurgeryThe role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet.Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?Treatment of diabetes with glucagon-like peptide-1 gene therapy.Nutrition and L and K-enteroendocrine cells.Glucose sensing and signalling; regulation of intestinal glucose transport.GLP-1 and energy balance: an integrated model of short-term and long-term controlThe future of incretin-based therapy: novel avenues--novel targets.Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects.Endogenous metabolites as ligands for G protein-coupled receptors modulating risk factors for metabolic and cardiovascular disease.
P2860
Q26862823-DE1BC8D4-95ED-4EB8-B1A2-AD2F175C1225Q27027920-6723F5E5-6BA6-4B58-8371-63C716B600FDQ28592795-8C7B4530-7898-4315-95D1-92026D0C03F1Q28730663-AA282037-BB12-4535-93D5-933E6F85C6E0Q33470938-53F119AC-A245-4C45-A0C5-6488A5EA3B8AQ33585686-027ABA28-E091-425E-9856-2AB25180D437Q33745485-9B67A59E-F04C-49C4-A89A-8872CEF19DF0Q33890272-719327DB-DCD2-44A5-A396-0BBF1A0ECB03Q34159708-A185CE3C-227C-4E8D-ADF7-F278AC58F76BQ34201215-2F0173CF-21A7-4068-861F-C5E040FF8D7AQ34341759-61DA7214-81DA-4FC7-8EA1-798D3F664A6CQ34412675-32F316D5-7AAE-419E-B671-6FF7F9B4AADCQ34426842-F306BA38-FD78-4CB6-8DBD-494B9BD9F5DDQ34468425-D428BE95-2893-421A-8EE1-1DE76320842AQ34500574-720056ED-E96F-470D-ABD5-303A06BA1082Q34627077-11F92F93-ACFD-49F8-8F5E-790587793F4CQ35416179-5FACD873-DDD2-414D-B228-EA6BB5E10512Q35689193-D4915B9A-1A95-440E-8E8E-85447A0567FEQ35760288-4099E0C8-B860-4192-85C4-86930322EDCCQ35858749-8E91A893-4B5F-43C0-9532-355C08884573Q35994290-0365F352-BABE-4D87-B269-894CDB59CA83Q36552750-D41C55BB-87FE-4CF0-9BDB-CB57125EC42EQ36615196-E78A6541-BF96-4922-8AB7-C69B005D067CQ36783865-887D07B0-D0BE-43AC-B150-52E9E261D8AEQ36791242-EB7BB548-7A4F-4AEA-A043-45440035F1FCQ36868293-F1E42DDF-8B86-4B92-B70B-0F6766691026Q36953864-4CC0FF19-06C7-437F-BBD2-6DA45F6DFF12Q37193390-DDD97D10-502E-49EC-B8A2-52486F586D86Q37204274-05FD7A9E-D618-44A2-AC0C-8293E1FCAC23Q37639656-4F529823-DB10-482C-862E-7363208B17BEQ37762333-C4FC3817-0081-48E0-B151-766776A5690FQ37779101-44408B29-F435-453C-A1CB-8C4DFD427573Q37804398-043FDB0B-2796-450B-B3AA-80FE69F464B8Q37814881-B00146CD-6D3C-4EC9-89B9-CA51257D9078Q37859449-168A6AC9-A764-413B-A326-1CFCD5E6F046Q37885717-48086364-2BB2-42CE-A8CB-04D3409E52A8Q37913528-8A7BFE24-1C4C-4BA1-B011-896AD182B066Q37983846-76CAB48F-CF99-40B1-B679-FA835D4AFEEDQ37988231-D698C61C-A963-47F8-8081-C3B0820574C3Q38067511-AC02D57D-CA6E-440F-9EDF-0046C0AC4887
P2860
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@en
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@nl
type
label
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@en
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@nl
prefLabel
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@en
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@nl
P2860
P1476
Molecular mechanisms underlying nutrient-stimulated incretin secretion.
@en
P2093
Helen E Parker
P2860
P356
10.1017/S146239940900132X
P577
2010-01-05T00:00:00Z